维普期刊资源整合服务平台（V6.5）

222篇 您的检索式：作者名="POCOCK SJ"

选中清除导出查看参考文献查看引证文献引用追踪共12页首页上一页第1页下一页末页 /12 跳转

	题名	作者	年代	出处	被引量
1	Red cell distri- bution width as a novel prognostic marker in heart failure: data from the Charm Program and the Duke Databank显示文摘	FELKER GM ALLEN LA POCOCK SJ	2007	J Am Coil Cardiol2007，50，：	1
2	Red cell distribution width as a novel prognostic marker in heart failure:data from the CHARM Program and the Duke Databank显示文摘	Felker GM Allen LA Pocock SJ		0，，1：	1
3	Rosiglitazone evaluated for cardiac outcomes and regulation of glycaemia in diabetes ( RECORD ): study design and protocol 显示文摘	Home PD Pocock SJ Beck-Nielsen H	2005	Diabetologia2005，48，9：	1
4	Issues in the reporting of epidemiological studies:a survey of recent practice显示文摘	Pocock SJ Collier TJ Dandreo KJ	2004	Brit Med J2004，329，7471：	1
5	Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank显示文摘	Felker GM Allen LA Pocock SJ		J Am Coil Cardiol0，50，1：	1
6	Associations of major bleeding and myo- cardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial 显示文摘	Mehran R Pocock SJ Stone GW	2009	Eur Heart J2009，30，12：	1
7	Rosiglita- zone evaluated for cardiovascular outcomes in oral agent combina- tion therapy for type 2 diabetes (RECORD) : a multicentre, ran- domized, open-label trial 显示文摘	HOME PD POCOCK SJ BECK-NIELSEN H	2009	Lancet2009，373，9681：	1
8	Rosiglita- zone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes (RECORD): Study design and protocol 显示文摘	Home PD Pocock SJ Beck-Nielsen H	2005	Diabetologia2005，48，9：	1
9	Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial显示文摘	POCOCK SJ SIMON R	1975	Biometrics1975，31，：	1
10	Red cell distribution width as novel prognostic marker in heart failure: Data from the CHARM pro- gram and the duke databank 显示文摘	Felker GM Allen LA Pocock SJ	2007	J Am Coil Cadiol2007，50，1：	1
11	Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a muhicentre, randomised,open-label trial显示文摘	Home PD Pocock SJ Beck-Nielsen H	2009	Lancet2009，373，9681：	1
12	Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank显示文摘	Felker GM Allen LA Pocock SJ	2007	J Am Coil Cardiol2007，50，1：	1
13	Red Cell Distribution Width as a Novel Prognostic Marker in Heart Failure Data From the CHARM Program and the Duke Databank显示文摘	Felker GM Allen LA Pocock SJ	2007	J Am Coil Cardiol2007，50，1：	1
14	Paclitaxel-eluting stents versus bare- metal stents in acute myocardial infarction显示文摘	Stone GW Lansky AJ Pocock SJ	2009	N Engl J Med2009，360，：	1
15	Insulin glargine and malignancy: an unwarranted alarm显示文摘	Pocock SJ Smeeth L	2009	Lancet2009，374，：	1
16	Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes(RECORD) : a muhicentre, randomised, open-label trial 显示文摘	Home PD Pocock SJ Nielsen HB	2009	Lancet2009，373，9681：	1
17	Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies 显示文摘	Pocock SJ Ariti CA MeMurray JJ	2013	Eur Heart J2013，34，19：	1
18	Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial显示文摘	POCOCK SJ SIMON R	1975	Biometrics1975，31，1：	1
19	Red cell distribution width as a novel prognostic marker in heart failure ; data from the CHARM Program and the Duke Databank显示文摘	Felker GM Allen LA Pocock SJ	2007	J Am Coll Cardiol2007，50，1：	1
20	Red cell dist ribution width as a novel prognostic marker in heart failure:data from the CHARM program and the duke databank显示文摘	Felker GM Allen LA Pocock SJ	2007	J Am Coll Cardiol2007，50，1：	1

返回顶部每页显示：

共12页首页上一页第1页下一页末页 /12 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示